2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Frontiers Development and Interpretation of Multiple Machine Learning Models for Predicting Postoperative Delayed Remission of Acromegaly Patients During Long-Term Follow-Up

Diffuse Hormonal Systems - Endotext - NCBI Bookshelf

Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance - Journal of Hepatology

Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas

Acromegaly - ScienceDirect

Acromegaly - ScienceDirect

Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

Ming SHEN, Medical Doctor, Doctor of Medicine, Fudan University, Shanghai, Hospital of Huashan

(PDF) How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review

Acromegaly SpringerLink

Chapters Archive - Page 11 of 44 - Endotext

Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma